TD Cowen analyst Steve Scala has reaffirmed his “Buy” rating for AstraZeneca (AZN), signaling continued confidence in the pharmaceutical giant’s…
Read MoreTD Cowen analyst Steve Scala has reaffirmed his “Buy” rating for AstraZeneca (AZN), signaling continued confidence in the pharmaceutical giant’s…
Read More